March 29th, 2016
The Massachusetts Lyme Legislative Task Force responds to a recent editorial from the Boston Globe, which opposed legislation to require insurance coverage for treatment of Lyme disease.
Dear Editors of the Boston Globe:
We were disappointed by your March 28 editorial criticizing the Lyme disease bill (H901/S502, An Act Relative to Lyme Disease Treatment Coverage[i]. Your arguments levied against the bill are outdated in terms of the science. Recent studies indicate that the bacterium that causes Lyme does in fact persist beyond a short course of antibiotics [ii][iii] and it has long been known that …